Discuss how epigenetic inheritance differs from classical Mendelian genetics and its implications for understanding human hereditary disorders.

Mendelian genetics explains heredity through the transmission of DNA sequence variants — discrete "factors" segregating independently. Epigenetic inheritance instead transmits chemical marks layered on that sequence, chiefly DNA methylation at cytosine bases, without altering the genetic code. A 2026 mouse study found ~7% of autosomal epigenetic inheritance patterns break Mendel's laws [1], showing the epigenome as a second, parallel layer of heritable information.

How epigenetic inheritance departs from the Mendelian model

• Mechanism: Mendelian traits arise from sequence variation; epigenetic traits arise from methylation, histone modification, chromatin remodelling and small-RNA transfer, which switch genes on or off without mutation [2].
• Ratios and predictability: methylation can appear on both alleles in offspring of parents lacking it, and can be sex-specific — patterns not predicted by segregation ratios [1].
• Paramutation and imprinting: one gene copy can alter its partner (paramutation confirmed at the Capn11 locus), and parent-of-origin imprinting overrides allelic equivalence; five new imprinted genes were identified [1].
• Reversibility and environment: unlike fixed mutations, marks are responsive to environment and diet, distinguishing intergenerational (direct exposure) from transgenerational transmission [2].
• Continuity, not rejection: ~93% of patterns still followed Mendel's laws — classical genetics is refined, not overturned [1].

Implications for human hereditary disorders

• Diagnosis of "unsolved" cases: many familial disorders show no causal sequence variant; methylation mapping offers a route where sequence-based diagnostics fail [3].
• Imprinting disorders: conditions such as Prader-Willi and Angelman syndromes arise from faulty imprinting, a directly epigenetic cause [2].
• Therapeutic promise: epigenetic marks are potentially reversible, unlike mutations, opening preventive and pharmacological avenues.
• Policy relevance for India: sequence-focused efforts like GenomeIndia, which has sequenced over 10,000 genomes, may need complementary epigenomic cohorts to capture disease risk fully [4].

The epigenome thus completes, rather than contradicts, the Mendelian account of heredity. Integrating epigenomic profiling into national genomics programmes, backed by clear ethical safeguards on multi-generational biological data, would strengthen precision medicine and advance SDG-3 on health and well-being.